0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Detection Methods Environmental Sources Food & Water Human Health Effects Nanoplastics Sign in to save

Microplastics and nanoplastics: Emerging drivers of hepatic pathogenesis and metabolic dysfunction

Hepatology forum/Hepatology forum (Online) 2025 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 53 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Yusuf Yılmaz

Summary

This review examines emerging evidence linking micro- and nanoplastic exposure to liver disease, including metabolic dysfunction-associated liver disease, cirrhosis, and liver cancer. Researchers found that these particles may contribute to liver damage through oxidative stress, inflammation, and disruption of metabolic pathways. The study highlights the need for further research into how environmental plastic contamination may be influencing the rising rates of liver disease worldwide.

Body Systems

Advanced liver disease, including cirrhosis and hepatocellular carcinoma (HCC), represents a major global health challenge, driven in part by the rising prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD). In parallel, micro-and nanoplastics (MNPs) have emerged as pervasive environmental contaminants with potential hepatotoxic effects. This review provides an in-depth analysis of current knowledge regarding the role of MNPs in the pathogenesis of cirrhosis and HCC, particularly in the context of the growing MASLD burden, and identifies key areas for future research. The literature search included original studies and review articles indexed in PubMed/MEDLINE, Web of Science, Scopus, and Google Scholar from January 1, 2014, to November 1, 2024. Evidence from animal models indicates that MNP exposure may induce hepatic changes resembling those seen in human MASLD and metabolic dysfunction-associated steatohepatitis (MASH) through both direct and indirect mechanisms. Importantly, MNPs may act as a "second hit" in the presence of pre-existing metabolic stress, potentially exacerbating liver injury. However, human data remain scarce, with only two small-scale studies investigating MNPs in clinical cohorts. Recent advances in analytical methods for quantifying MNPs in blood present new opportunities to explore their association with MASLD, cirrhosis, and HCC in human populations. While significant progress has been made in understanding MNP-induced hepatotoxicity in experimental models, their clinical relevance to human liver disease progression remains largely unexplored. Further multidisciplinary research integrating environmental science, molecular biology, and clinical hepatology is urgently needed.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Impact of microplastics and nanoplastics on liver health: Current understanding and future research directions

This review summarizes what scientists know about how micro- and nanoplastics affect the liver, which is one of the first organs exposed because it processes everything absorbed from the gut. The particles trigger oxidative stress, disrupt energy metabolism, cause cell death, and promote inflammation, and may contribute to conditions like fatty liver disease and liver fibrosis. The paper also highlights how plastics can disturb the gut microbiome, which communicates with the liver through the gut-liver axis and may amplify liver damage.

Article Tier 2

Exposure to microplastics and liver oncogenesis: A comprehensive review on molecular mechanisms and pathogenic pathways

Researchers reviewed mechanisms by which microplastic exposure may promote liver cancer, identifying oxidative stress, mitochondrial dysfunction, inflammatory signaling, and epigenetic disruption as key pathways, while noting that microplastics can also carry heavy metals and organic pollutants that synergistically amplify hepatotoxic and carcinogenic risk.

Article Tier 2

Emerging threat of environmental microplastics: A comprehensive analysis of hepatic metabolic dysregulation and hepatocellular damage (Review)

This review summarizes existing research on how microplastics damage the liver, which is a key organ for filtering toxins from the body. Studies show that microplastics can cause liver tissue damage, trigger cell death, and disrupt fat metabolism, with smaller particles and longer exposure causing worse effects. The findings highlight the liver as a particularly vulnerable organ because it accumulates microplastics that enter the body through food and water.

Article Tier 2

Hepatotoxic Mechanisms of Micro- and Nanoplastics in Animal Models: A Scoping Review with Human Health Implications

This scoping review examines hepatotoxic mechanisms of micro- and nanoplastics in animal models, identifying oxidative stress, inflammation, lipid peroxidation, and epigenetic alterations as the primary pathways through which plastic particles damage liver tissue.

Systematic Review Tier 1

Nanoplastics and Microplastics May Be Damaging Our Livers

This systematic review summarizes research on how micro- and nanoplastics may damage the liver. Since the liver is the body's main detoxification organ, it plays a key role in processing plastic particles that enter the body through food, water, and air, and the evidence suggests these particles can cause inflammation, oxidative stress, and other liver problems.

Share this paper